DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OMNIPAQUE 12

« Back to Dashboard

All Clinical Trials for Omnipaque 12

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00478556	Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT	Completed	GE Healthcare	Phase 4	2007-08-01	Patients who are scheduled by their health care provider for routine computed tomography (CT) scan will be asked to participate in this study. The primary purpose is to determine if there is a difference in patient preference for Omnipaque versus Gastroview as oral contrast for abdominal pelvic CT. A secondary objective is to evaluate if there is significant difference in bowel opacification for the two agents.
NCT00478556	Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT	Completed	University of Alabama at Birmingham	Phase 4	2007-08-01	Patients who are scheduled by their health care provider for routine computed tomography (CT) scan will be asked to participate in this study. The primary purpose is to determine if there is a difference in patient preference for Omnipaque versus Gastroview as oral contrast for abdominal pelvic CT. A secondary objective is to evaluate if there is significant difference in bowel opacification for the two agents.
NCT00587132	Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma	Terminated	ChiRhoClin, Inc.	Phase 1/Phase 2	2006-11-01	The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population.
NCT00587132	Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma	Terminated	Mayo Clinic	Phase 1/Phase 2	2006-11-01	The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population.

Clinical Trial Conditions for Omnipaque 12

Condition Name

Condition Name for Omnipaque 12
Intervention	Trials
Renal Function	1
Contrast-induced Nephropathy	1
Hormone Replacement Therapy	1
Adenomyosis	1

Condition MeSH

Condition MeSH for Omnipaque 12
Intervention	Trials
Coronary Artery Disease	2
Myocardial Ischemia	2
Neuronal Ceroid-Lipofuscinoses	1
Coronary Disease	1

Clinical Trial Locations for Omnipaque 12

Trials by Country

Trials by Country for Omnipaque 12
Location	Trials
United States	10
Colombia	1
France	1
Korea, Republic of	1

Trials by US State

Trials by US State for Omnipaque 12
Location	Trials
Minnesota	2
California	1
North Carolina	1
Pennsylvania	1
Ohio	1

Clinical Trial Progress for Omnipaque 12

Clinical Trial Phase

Clinical Trial Phase for Omnipaque 12
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	1
Phase 2	1

Clinical Trial Status

Clinical Trial Status for Omnipaque 12
Clinical Trial Phase	Trials
Completed	7
Recruiting	5
Not yet recruiting	4

Clinical Trial Sponsors for Omnipaque 12

Sponsor Name

Sponsor Name for Omnipaque 12
Sponsor	Trials
GE Healthcare	2
University of California, San Francisco	1
Mayo Clinic	1

Sponsor Type

Sponsor Type for Omnipaque 12
Sponsor	Trials
Other	16
Industry	11
NIH	3